SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCNs sharp rise has sparked breakout and momentum chatter, with some traders speculating about a Robinhood connection; that partnership talk remains unconfirmed. Bulls point to Zebecs payroll and payments expansion, while skeptics question whether real usage and token demand are strong enough to sustain the move.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop next-generation 10 kV silicon-carbide power technology is driving attention, with traders viewing it as technology and domestic-manufacturing validation. The reaction is bullish, though some caution that the prototype awards financial terms are undisclosed and it may not translate into meaningful near-term revenue.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak surged after Zenkuda and KSI-501 met primary endpoints in the Phase 3 DAYBREAK trial for wet AMD, prompting traders to weigh the results and potential FDA filing against established treatments. The rally has fueled bullish short-squeeze and pipeline optimism, alongside debate over valuation before approval, competition, future financing or dilution, and profit-taking.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic equity investment in Summit and clinical collaboration on ivonescimab combinations are driving attention, with traders viewing the deal as a boost to funding and confidence in the cancer drug. Some speculate it could lead to an acquisition or short covering, while others caution that it is not a buyout and does not resolve the pending FDA decision.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFA acceptance of VantageScore for Fannie Mae and Freddie Mac mortgages, alongside scrutiny of FICOs pricing, has raised concerns that competition could weaken its credit-scoring moat and pricing power. Bears see further downside risk, while bulls argue the selloff may be overdone given FICOs continued growth and entrenched business.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Analyst upgrades and optimism about Astera Labs role in AI data-center connectivity are supporting the bullish case, while traders debate whether strong infrastructure demand can justify the valuation. The discussion is also dominated by sharp, volatile price swings, with some traders buying dips and others expecting further pullbacks.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

A sharp, high-volume AMP rebound is driving attention, with traders debating whether it marks a sustained technical reversal or another short-lived pump. Bulls point to broader altcoin strength and Flexas payments potential, while skeptics cite AMPs steep long-term decline and the lack of clear new adoption news.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

Discussion centers on XRP-linked ETF demand and regulatory optimism, with traders pointing to reported ETF inflows and possible spot ETF approvals or Clarity Act progress. Bullish views compete with concerns about XRPs pullback, broader crypto weakness, and whether the momentum can hold; some posts also confuse the ETF ticker with XRP itself.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

AVAXs rebound is drawing attention around tokenization and institutional-adoption themes, with traders pointing to reports of NYSE testing Avalanche for tokenized securities and Hanwha building a platform on the network, alongside broader altcoin momentum. Bulls see rising volume and a potential breakout, while skeptics argue the move may be speculative and vulnerable to a pullback.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarnas shares remain under pressure after its reduced guidance, which traders attribute partly to softness in Germany and near-term investment spending; many are frustrated by the persistent decline and question profitability and management communication. Bulls counter that improving business metrics, the Apple device-financing partnership, and CEO share purchases could support longer-term growth, though the payoff remains uncertain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DOMH trading volume continues to be sizable but it looks like the $5M already may have been used, as the stock price begins to make its way back to $2…not good

StockTwits for iOS

Dominari Holdings Inc

 trading volume continues to be sizable but it looks like the $5M already may have been used, as the stock price begins to make its way back to $2…not good